THV Summit 2022
Published: 10 January 2023
4m 55sPart 1 | Session 1 Introduction to the day Lars Søndergaard, Darren Mylotte, Andreas Rück, Prof Marek Grygier
8m 9sPart 1 | Session 2 Case 1 – Karolinska University – TAVI in a Small Anatomy – Presentation
22m 43sPart 1 | Session 3 Case 1 – Karolinska University – TAVI in a Small Anatomy – Panel Discussion Lars Søndergaard, Darren Mylotte, Prof Marek Grygier, Andreas Rück
40m 12sPart 1 | Session 4 Case 1 – Karolinska University – TAVI in a Small Anatomy – Live Case Lars Søndergaard, Andreas Rück, Prof Marek Grygier, Darren Mylotte
3m 37sPart 1 | Session 5 Case 2 – Kerckhoff Heart Center – TAVI in Challenging Femoral Access – Introduction Lars Søndergaard, Prof Marek Grygier
For this 2nd edition of the THV Summit, which was hosted in Amsterdam on (30 June - 1 July 2022) distinguished chair and faculty members present a full day of live cases from two renowned TAVI centres in EMEA for a case-based program dedicated to Aortic Valve Therapies.
During the THV Summit, experienced structural heart valve provided expert insight into the essentials of the TAVI procedure with two live cases. Each case focuses on a specific topic and patient profile using a step-by-step approach to review in detail the key factors to optimising valve therapy from pre-procedural planning to outcomes with special emphasis on efficiency and lifetime management of patients.
More from this programme
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Poznan University of Medical Sciences, Poznan, Poland
Dr Darren Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands.
Dr Won-Keun Kim is Director of Structural Heart Disease / TAVI at the Kerckhoff Heart Center, Bad Nauheim, Germany.
Dr Won-Keun Kim is Director of Structural Heart Disease / TAVI at the Kerckhoff Heart Center, Bad Nauheim, Germany. Between 2012-2016 Dr Kim served as Interdisciplinary Consultant, Cardiology / Cardiac Surgery, and Associate Director of the Interventional Cardiology Training Program also at the Kerckhoff Heart Center, where he previously worked as a specialist in cardiology, interventional cardiology and cardiovascular imaging.